Clinico-pathological predictors of clinical complete response in rectal cancer

Heald, 1982, The mesorectum in rectal cancer surgery—The clue to pelvic recurrence?, Br. J. Surg., 69, 613, 10.1002/bjs.1800691019 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N. Engl. J. Med., 345, 638, 10.1056/NEJMoa010580 Maas, 2010, Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol., 11, 835, 10.1016/S1470-2045(10)70172-8 Martin, 2012, Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer, Br. J. Surg., 99, 918, 10.1002/bjs.8702 Hospers, 2020, Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: the randomized RAPIDO trial, J. Clin. Oncol., 38, 4006, 10.1200/JCO.2020.38.15_suppl.4006 Conroy, 2020, Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: final results of PRODIGE 23 phase III trial, a UNICANCER GI trial, J. Clin. Oncol., 38, 4007, 10.1200/JCO.2020.38.15_suppl.4007 Garcia-Aguilar, 2020, Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial, J. Clin. Oncol., 38, 4008, 10.1200/JCO.2020.38.15_suppl.4008 Ryan, 2016, Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review, Color. Dis., 18, 234, 10.1111/codi.13207 Al-Sukhni, 2016, Predictors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer, Ann. Surg. Oncol., 23, 1177, 10.1245/s10434-015-5017-y Habr-Gama, 2010, Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization, Dis. Colon. Rectum., 53, 1692, 10.1007/DCR.0b013e3181f42b89 Renehan, 2016, Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis, Lancet Oncol., 17, 174, 10.1016/S1470-2045(15)00467-2 Fan, 2006, Understanding receiver operating characteristic (ROC) curves, CJEM, 8, 19, 10.1017/S1481803500013336 Hung, 2017, Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients, Int. J. Colorectal Dis., 32, 1775, 10.1007/s00384-017-2907-4 Li, 1998, Serum gamma-glutamyltransferase and alkaline phosphatase during experimental liver metastases. Detection of tumour-specific isoforms and factors affecting their serum levels, Eur. J. Cancer, 34, 1935, 10.1016/S0959-8049(98)00196-8 Tisdale, 2002, Cachexia in cancer patients, Nat. Rev. Cancer, 2, 862, 10.1038/nrc927 Sun, 2018, Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis, Int. J. Colorectal Dis., 33, 1419, 10.1007/s00384-018-3128-1 Trejo-Avila, 2021, Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis, Int. J. Colorectal Dis., 36, 1077, 10.1007/s00384-021-03839-4 Olmez, 2020, The impact of sarcopenia on pathologic complete response following neoadjuvant chemoradiation in rectal cancer, Langenbeck's Arch. Surg., 405, 1131, 10.1007/s00423-020-01983-z Guthrie, 2013, Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer, Br. J. Cancer, 109, 131, 10.1038/bjc.2013.291 Spicer, 2012, Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells, Cancer Res., 72, 3919, 10.1158/0008-5472.CAN-11-2393 Xiao, 2015, A low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in pathological T3N0 rectal cancer patients following total mesorectal excision, J. Cancer, 6, 616, 10.7150/jca.11727 Pedrazzani, 2017, Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer, Sci. Rep., 7, 1494, 10.1038/s41598-017-01652-0 Kitayama, 2011, Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer, BMC Cancer, 11, 64, 10.1186/1471-2407-11-64 Kim, 2019, Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy, Tumori, 105, 434, 10.1177/0300891618792476 Dudani, 2019, Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation, BMC Cancer, 19, 664, 10.1186/s12885-019-5892-x Zhang, 2016, Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study, Oncotarget, 7, 5053, 10.18632/oncotarget.6469 Sun, 2017, A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies, Oncotarget, 8, 67732, 10.18632/oncotarget.18821